PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 27 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Extracts selectively inhibited COX-2 and iNOS enzymes in a murine macrophage model [PMID: 28962255]
Polyphenolic-rich fractions demonstrated pronounced alpha-glucosidase-inhibitory activity (IC50: 0.30 mg/ml) [PMID: 23107721]
Extracts reduced the proliferation of colon, stomach, bladder, and liver cancer cells in vitro [PMID: 23017386]
Solvent extracts showed broad-spectrum antifungal activity against weak-acid resistant yeasts and potential anti-quorum sensing activity against Chromobacterium violaceum [PMID: 30380618, 30934945]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 39199222 (2024) — Phytochemical Composition and Toxicological Screening of Anise Myrtle and Lemon Myrtle Using Zebrafish Larvae. · Antioxidants (Basel, Switzerland)
- 2.PMID: 38792121 (2024) — LC-ESI-QTOF-MS/MS Identification and Characterization of Phenolic Compounds from Leaves of Australian Myrtles and Their Antioxidant Activities. · Molecules (Basel, Switzerland)
- 3.PMID: 28962255 (2014) — Anti-inflammatory potential of native Australian herbs polyphenols. · Toxicology reports
- 4.PMID: 30380618 (2018) — Mechanism of Action against Food Spoilage Yeasts and Bioactivity of Tasmannia lanceolata, Backhousia citriodora and Syzygium anisatum Plant Solvent Extracts. · Foods (Basel, Switzerland)
- 5.PMID: 40916307